About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The goal of the Shock, Organic Dysfunction and Resuscitation Research Group (SODIR) is comprehensive, innovative research into the areas of shock, acute respiratory failure, acute kidney failure, organic dysfunction, resuscitation and critical patient monitoring. In addition, the research group has a special interest in applying artificial intelligence as an instrument to find innovative solutions for critical patients.
PMID: 33674125 Journal: Medicina Intensiva Year: 2021 Reference: Med Intensiva (Engl Ed). 2021 Mar 2. pii: S0210-5691(21)00008-5. doi: 10.1016/j.medin.2021.01.004. Impact factor: 2.491 Publication type: Letter or abstract Authors: Mera, A, Ruiz-Rodriguez, J C, Sanchez, A, Ferrer, R et al. DOI: 10.1016/j.medin.2021.01.004
PMID: 32429799 Journal: Surgical Infections Year: 2021 Reference: Surg Infect (Larchmt). 2021 Mar;22(2):222-226. doi: 10.1089/sur.2020.031. Epub 2020 May 20. Impact factor: 2.15 Publication type: Paper in international publication Authors: Perez-Cameo, Cristina, Lung, Mayli, Hidalgo, Ernesto, Gomez-Gavara, Concepcion, Vargas, Victor, Nuvials, Xavier, Los-Arcos, Ibai, Castells, Lluis, Len, Oscar et al. DOI: 10.1089/sur.2020.031
PMID: 33652455 Journal: Current Opinion in Anesthesiology Year: 2021 Reference: Curr Opin Anaesthesiol. 2021 Apr 1;34(2):99-106. doi: 10.1097/ACO.0000000000000959. Impact factor: 2.706 Publication type: Review in international publication Authors: Garcia-de-Acilu, Marina, Mesquida, Jaume, Gruartmoner, Guillem, Ferrer, Ricard et al. DOI: 10.1097/ACO.0000000000000959
PMID: 33367993 Journal: Canadian Journal of Anesthesia-Journal canadien d anesthesie Year: 2021 Reference: Can J Anaesth. 2021 Mar;68(3):434-435. doi: 10.1007/s12630-020-01887-y. Epub 2020 Dec 24. Impact factor: 5.063 Publication type: Letter or abstract Authors: Loor, Karina, Alvarez, Antonio, Felipe Montiel, Almudena, Ferrer, Ricard, Roca, Oriol, Garcia-de-Acilu, Marina, Clofent, David, Landivar, Jose Cardoso, Polverino, Eva, Culebras Amigo, Mario et al. DOI: 10.1007/s12630-020-01887-y
On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.
Hybrids VITA, developed together with Medical Simulator, reproduces different clinical scenarios for training on how to prevent, diagnose and treat possible complications of ECMO, which is a very complex technique.
Extracorporeal Cardiopulmonary Resuscitation (ECPR) offers therapeutic options for patients in whom conventional cardiopulmonary resuscitation techniques fail to restore the heartbeat.
